Cargando…

Anti‐cachexia therapy should target metabolism, inflammatory cytokines, and androgens in hormone‐independent cancers

Detalles Bibliográficos
Autor principal:	Lambert, Charles Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517352/ https://www.ncbi.nlm.nih.gov/pubmed/34319012 http://dx.doi.org/10.1002/jcsm.12762

Ejemplares similares

Pathophysiological Role of Hormones and Cytokines in Cancer Cachexia
por: Kim, Hyun Jung, et al.
Publicado: (2012)

Novel mechanism of ghrelin therapy for cachexia
por: Hatanaka, Michiyoshi, et al.
Publicado: (2015)

Open source in cachexia?
por: Stemmler, Britta, et al.
Publicado: (2015)

Does COVID‐19‐related cachexia mimic cancer‐related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management
por: Kumar, Nagi B.
Publicado: (2021)

Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
por: Felten, Renaud, et al.
Publicado: (2022)

Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?
por: Ishida, Junichi, et al.
Publicado: (2017)

Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued?
por: Cagnacci, A., et al.
Publicado: (2020)

Should the FDA's criteria for the clinical efficacy of cachexia drugs be changed? Is Ostarine safe and effective?
por: Lambert, Charles Paul
Publicado: (2021)

Identification of Cause of Posttransplant Cachexia by PCR
por: Guitard, Joelle, et al.
Publicado: (2012)

Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets
por: Slessarev, Marat, et al.
Publicado: (2020)

Hormone levels following surgical and medical castration: defining optimal androgen suppression
por: Schweizer, Michael T, et al.
Publicado: (2018)

Evidence for an effect of ACE inhibitors on cancer cachexia
por: Schanze, Nancy, et al.
Publicado: (2012)

Cardiac Cachexia - A Window to the Wasting Disorders
por: Coats, Andrew J Stewart
Publicado: (2018)

Comment on 'Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer' by Xie et al.
por: Ding, Ping'an, et al.
Publicado: (2023)

Re-induction of hormone sensitivity to diethylstilboestrol in androgen refractory prostate cancer patients following chemotherapy
por: Cox, R A, et al.
Publicado: (2008)

Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data
por: Lamy, Pierre-Jean, et al.
Publicado: (2020)

Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
por: Meng, Jialin, et al.
Publicado: (2022)

What Role Do Inflammatory Cytokines Play in Cancer Cachexia?
por: Malla, Jyothirmai, et al.
Publicado: (2022)

What should the target blood pressure goals be?
por: Aronow, Wilbert S.
Publicado: (2016)

Irisin – a myokine potentially bridging muscle and fat tissue in cachexia
por: Konishi, Masaaki, et al.
Publicado: (2015)

Metabolic syndrome definition in adolescents should incorporate insulin resistance
por: Nogueira-de-Almeida, Carlos Alberto
Publicado: (2020)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

Low-Level Laser Therapy for Androgenic Alopecia
por: Tin, Sim Sai, et al.
Publicado: (2014)

Should active case finding be conducted among patients with respiratory symptoms independently of local epidemiological settings?
por: Gabardo, Betina Mendez Alcântara, et al.
Publicado: (2019)

Biomarkers and mechanisms associated with cancer‐induced cardiac cachexia: A systematic review
por: Bagnall, Lisa, et al.
Publicado: (2023)

Determining the anti-coagulant-independent anti-cancer effects of heparin
por: Solari, V, et al.
Publicado: (2010)

WHO SHOULD RECEIVE NOVEL HORMONAL THERAPY WITH ANDROGEN DEPRIVATION THERAPY IN METASTATIC HORMONE SENSITIVE PROSTATE CANCER?
por: Omrčen, Tomislav
Publicado: (2019)

Studies on the Regulation of Arginine Metabolism in Cyanobacteria Should Include Mixotrophic Conditions
por: Flores, Enrique
Publicado: (2021)

Induction of cachexia in mice
por: Tisdale, M
Publicado: (1999)

Should patient enrollment criteria for anti‐VEGF phase III trials be reconsidered
por: Hanhart, Joel, et al.
Publicado: (2023)

Reply: Prostate cancer, insulin and androgen deprivation therapy
por: Lehrer, S
Publicado: (2003)

Androgen deprivation therapy in high risk prostate cancer
por: Van Dams, Ritchell, et al.
Publicado: (2019)

Leptin as an independent marker of metabolic syndrome
por: Joob, Beuy, et al.
Publicado: (2017)

Comment on ‘The expression landscape of cachexia‐inducing factors in human cancers’ by Freire et al.
por: Xie, Longxiang, et al.
Publicado: (2021)

Comment on ‘The expression landscape of cachexia‐inducing factors in human cancers’ by Freire et al.
por: Song, Shiyu, et al.
Publicado: (2020)

Comment on ‘COVID‐19: a major cause of cachexia and sarcopenia’ by Morley et al.
por: Zhou, Ling, et al.
Publicado: (2020)

Nasal or Nasopharyngeal Tuberculosis Should be Considered in the Initial Diagnosis of Sino-Nasal Inflammatory Diseases
por: Min, Hyun Jin, et al.
Publicado: (2017)

Epicardial Adipose Tissue Should Be Evaluated with Other Inflammatory Markers in Patients with Subclinical Hypothyroidism
por: Balta, Sevket, et al.
Publicado: (2013)

ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer
por: Freeman, Michael R., et al.
Publicado: (2019)

What dose of anti-snake venom should be given in severe neuroparalytic snake bite?
por: Agrawal, Avinash, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tjq6oue1optng9o5a9m973o51k